Annual Total Debt
$25.56 M
+$401.00 K+1.59%
December 31, 2023
Summary
- As of February 8, 2025, VIRX annual total debt is $25.56 million, with the most recent change of +$401.00 thousand (+1.59%) on December 31, 2023.
- During the last 3 years, VIRX annual total debt has risen by +$19.38 million (+313.66%).
- VIRX annual total debt is now at all-time high.
Performance
VIRX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$16.91 M
-$1.91 M-10.14%
September 30, 2024
Summary
- As of February 8, 2025, VIRX quarterly total debt is $16.91 million, with the most recent change of -$1.91 million (-10.14%) on September 30, 2024.
- Over the past year, VIRX quarterly total debt has dropped by -$8.64 million (-33.83%).
- VIRX quarterly total debt is now -33.84% below its all-time high of $25.56 million, reached on September 30, 2023.
Performance
VIRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
VIRX Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.6% | -33.8% |
| 3 y3 years | +313.7% | -33.8% |
| 5 y5 years | +313.7% | -33.8% |
VIRX Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +366.5% | -33.8% | +222.3% |
| 5 y | 5-year | at high | +366.5% | -33.8% | -100.0% |
| alltime | all time | at high | +366.5% | -33.8% | -100.0% |
Viracta Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.91 M(-10.1%) |
| Jun 2024 | - | $18.82 M(-0.2%) |
| Mar 2024 | - | $18.86 M(-26.2%) |
| Dec 2023 | $25.56 M(+1.6%) | $25.56 M(-0.0%) |
| Sep 2023 | - | $25.56 M(+0.0%) |
| Jun 2023 | - | $25.55 M(+0.0%) |
| Mar 2023 | - | $25.54 M(+1.5%) |
| Dec 2022 | $25.16 M | $25.16 M(+379.4%) |
| Sep 2022 | - | $5.25 M(-1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $5.33 M(-1.4%) |
| Mar 2022 | - | $5.41 M(-1.3%) |
| Dec 2021 | $5.48 M(-11.3%) | $5.48 M(-5.1%) |
| Sep 2021 | - | $5.77 M(-0.8%) |
| Jun 2021 | - | $5.82 M(-7.0%) |
| Mar 2021 | - | $6.26 M(+1.3%) |
| Dec 2020 | $6.18 M | $6.18 M(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00 |
FAQ
- What is Viracta Therapeutics annual total debt?
- What is the all time high annual total debt for Viracta Therapeutics?
- What is Viracta Therapeutics annual total debt year-on-year change?
- What is Viracta Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly total debt year-on-year change?
What is Viracta Therapeutics annual total debt?
The current annual total debt of VIRX is $25.56 M
What is the all time high annual total debt for Viracta Therapeutics?
Viracta Therapeutics all-time high annual total debt is $25.56 M
What is Viracta Therapeutics annual total debt year-on-year change?
Over the past year, VIRX annual total debt has changed by +$401.00 K (+1.59%)
What is Viracta Therapeutics quarterly total debt?
The current quarterly total debt of VIRX is $16.91 M
What is the all time high quarterly total debt for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly total debt is $25.56 M
What is Viracta Therapeutics quarterly total debt year-on-year change?
Over the past year, VIRX quarterly total debt has changed by -$8.64 M (-33.83%)